Dodecafluoropentane Emulsion in Acute Ischemic Stroke: A Phase Ib/II Randomized and Controlled Dose-Escalation Trial
- 1 August 2019
- journal article
- research article
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 30 (8) , 1244-1250.e1
Abstract
No abstract availableKeywords
Funding Information
- University of Arkansas for Medical Sciences
- National Institutes of Health (UL1TR0000039)
This publication has 20 references indexed in Scilit:
- Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion ImagingNew England Journal of Medicine, 2018
- Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and InfarctNew England Journal of Medicine, 2018
- Dodecafluoropentane Emulsion Extends Window for tPA Therapy in a Rabbit Stroke ModelMolecular Neurobiology, 2015
- Dodecafluoropentane emulsion delays and reduces MRI markers of infarction in a rat stroke model: a preliminary reportMagnetic Resonance Imaging, 2015
- Dodecafluoropentane Emulsion (DDFPe) Decreases Stroke Size and Improves Neurological Scores in a Permanent Occlusion Rat Stroke ModelThe Open Neurology Journal, 2014
- Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic StrokeJAMA, 2013
- Dodecafluoropentane Emulsion Decreases Infarct Volume in a Rabbit Ischemic Stroke ModelJournal of Vascular and Interventional Radiology, 2012
- Recombinant Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the United StatesStroke, 2011
- Hypoxia Due to Shunts in Pig Lung Treated with O2 and Fluorocarbon-derived Intravascular MicrobubblesArtificial Cells, Blood Substitutes, and Biotechnology, 2010
- Intravascular Fluorocarbon-stabilized Microbubbles Protect Against Fatal Anemia in RatsArtificial Cells, Blood Substitutes, and Biotechnology, 2006